DA
IRWD icon

Duality Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Duality Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58,915
Closed -$513K – 266
2024
Q1 		$513K Sell
58,915
-5,927
-9% -$71.9K 0.05% 452
2023
Q4 		$742K Sell
64,842
-8,966
-12% -$88.7K 0.08% 360
2023
Q3 		$711K Buy
73,808
+36,544
+98% +$358K 0.09% 359
2023
Q2 		$396K Buy
37,264
+3,453
+10% +$37.1K 0.05% 414
2023
Q1 		$356K Sell
33,811
-41,198
-55% -$462K 0.04% 465
2022
Q4 		$929K Sell
75,009
-101,239
-57% -$1.15M 0.11% 330
2022
Q3 		$1.83M Buy
176,248
+122,504
+228% +$1.39M 0.2% 202
2022
Q2 		$620K Buy
53,744
+37,834
+238% +$446K 0.06% 430
2022
Q1 		$200K Buy
+15,910
New +$182K 0.02% 603
2021
Q1 		– Sell
-142,346
Closed -$1.62M – 621
2020
Q4 		$1.62M Buy
142,346
+21,276
+18% +$233K 0.12% 258
2020
Q3 		$1.09M Buy
+121,070
New +$1.2M 0.07% 353

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Duality Advisers's IRWD Position: Q2 2024 in Review

Duality Advisers sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 58,915 shares — an estimated $513K sold.

Duality Advisers first reported a position in IRWD in Q3 2020 and held it in 11 quarters. The position peaked at $1.83M in Q3 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Duality Advisers reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 58,915 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $513K.
  • Duality Advisers first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 11 quarters.
  • Duality Advisers's Ironwood Pharmaceuticals position peaked at $1.83M in Q3 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.